Company page

Genocea Biosciences Inc

Genocea Biosciences Inc, trading under the ticker GNCAQ, is a public company based in the United States with a market capitalization of $59 million. The company focuses on developing innovative immunotherapies for cancer and infectious diseases. Genocea aims to harness the power of the immune system to create effective treatments.